Atopic dermatitis (eczema): open trials in United States

33 open trials have a site in United States. Registry data; only the trial team decides who can take part.

NCT00605878
Studies of Skin Microbes in Healthy People and in People With Skin Conditions
Research · National Human Genome Research Institute (NHGRI)
National Institutes of Health Clinical Center, Bethesda
Registry updated 2026-11-05
NCT01631617
Effects of Treatments on Atopic Dermatitis
Trial Treatment · Phase 2 · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institutes of Health Clinical Center, Bethesda
Registry updated 2026-11-05
NCT06807281
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
Trial Treatment · Phase 3 · Pfizer
Cahaba Dermatology Skin Health Center, Birmingham · Medical University of South Carolina - South Carolina Translational Research Nexus Clinic, Charleston · Tribe Clinical Research LLC, Greenville · Dawes Fretzin Clinical Research Group, LLC, Indianapolis · Solutions Through Advanced Research, Jacksonville · Ada West Research - Meridian, Meridian · Arkansas Research Trials, North Little Rock · Texas Dermatology and Laser Specialists, San Antonio · Investigational Drug Service - Rady Childrens Hospital-San Diego, San Diego · University of California, San Diego / Rady Children's Hospital, San Diego, San Diego · Saint Louis University, St Louis
Registry updated 2026-11-05
NCT07216027
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
Trial Treatment · Phase 2 · Pfizer
Marvel Clinical Research, Huntington Beach · Apex Clinical Research Center, LLC. - Lorain, Lorain · Metropolis Dermatology - DTLA, Los Angeles · Gsi Clinical Research, Margate · Apex Clinical Research Center, LLC, Mayfield Heights · Skin Research of South Florida, Miami · Northridge Clinical Trials, Northridge · Paddington Testing Co Inc, Philadelphia · Mayo Clinic Hospital, Phoenix · Mayo Clinic Specialty Building, Phoenix · UPMC Department of Dermatology, Pittsburgh · Clinical Science Institute, Santa Monica · Mayo Clinic, Scottsdale · Montefiore - Jacobi Dermatology Clinic, The Bronx · Montefiore - The Dermatology Center, The Bronx · Montefiore - Clinical Research Center, The Bronx · Montefiore - Greene Medical Arts Pavillion, The Bronx · Montefiore Medical Center, The Bronx
Registry updated 2026-11-05
NCT07916480
Roflumilast Cream 0.3% for Moderate to Severe Atopic Dermatitis
Trial Treatment · Phase 3 · Arcutis Biotherapeutics, Inc.
Chicago
Registry updated 2026-11-04
NCT06096857
Cardamom and Topical Roseomonas in Atopic Dermatitis
Trial Treatment · Phase 2 · National Institute of Allergy and Infectious Diseases (NIAID)
National Institutes of Health Clinical Center, Bethesda
Registry updated 2026-10-30
NCT05735483
A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis
Trial Treatment · Phase 3 · Eli Lilly and Company
Great Lakes Research Group, Inc., Bay City · The University of Texas Health Science Center at Houston, Bellaire · Clinical Research Center of Alabama, Birmingham · Treasure Valley Medical Research, Boise · Massachusetts General Hospital, Boston · Medical University of South Carolina, Charleston · Northwestern University, Chicago · Wright State Physicians, Fairborn · UConn Health, Farmington · First OC Dermatology, Fountain Valley · Solutions Through Advanced Research, Jacksonville · Dartmouth Hitchcock Medical Center, Lebanon · Dermatology Research Associates, Los Angeles · Medical College of Wisconsin, Milwaukee · Arkansas Research Trials, North Little Rock · Allergy and Asthma Specialist, Owensboro · Phoenix Children s Hospital, Phoenix · Integrative Skin Science and Research - Location 2, Sacramento · Texas Dermatology and Laser Specialists, San Antonio · ForCare Clinical Research, Tampa · Respiratory Medicine Research Institute of Michigan, PLC, Ypsilanti
Registry updated 2026-10-26
NCT07453602
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
Trial Treatment · Phase 1 · Arcutis Biotherapeutics, Inc.
College Station · Fair Lawn · Miami · Miami · Plainfield · San Antonio · South Jordan
Registry updated 2026-10-23
NCT07746427
Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis
Trial Treatment · Weill Medical College of Cornell University
Columbia University Irving Medical Center, New York · Weill Cornell Medicine, New York
Registry updated 2026-10-23
NCT07783425
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema
Trial Treatment · Phase 3 · Pfizer
Alexandria Associates in Dermatology, Arlington · Treasure Valley Medical Research, Boise · Dermatology Trial Associates, Inc., Bryant · Best Skin Research, LLC, Camp Hill · Derm Texas, Dallas · Dermatology Treatment and Research Center, Dallas · Marvel Clinical Research, Huntington Beach · Maryland Laser Skin and Vein, Hunt Valley · Dawes Fretzin Clinical Research Group, LLC, Indianapolis · California Allergy & Asthma Medical Group, Los Angeles · Marietta Dermatology Clinical Research, Inc., Marietta · Clinical Neuroscience Solutions, LLC., Memphis · Northridge Clinical Trials, LLC, Northridge · Clinical Neuroscience Solutions, LLC, Orlando · Alliance Dermatology & MOHS Center, Phoenix · Stryde Research-Epiphany Dermatology, Southlake · Complete Dermatology, Sugar Land · Revival Research Institute, LLC, Troy · Vital Prospects Clinical Research Institute., PC, Tulsa · Respiratory Medicine Research Institute of Michigan, PLC, Ypsilanti
Registry updated 2026-10-22
NCT07645820
Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares
Research · Castle Biosciences Incorporated
Derm Research Institute, PLC, Caledonia · Advanced Dermatology and Cosmetic Surgery - Henderson, Henderson · Las Vegas Dermatology, Las Vegas · U.S. Dermatology Partners Lee's Summit, Lee's Summit · DCOL Center for Clinical Research, Longview · James Y. Wang MD, Inc, Los Angeles · Harrison Dermatology, Missouri City · West Virginia Research Institute, Morgantown · Virginia Clinical Research, Inc., Norfolk · U.S. Dermatology Partners, Phoenix · StracSkin, PLLC, Portsmouth · U.S. Dermatology Partners Rockville, Rockville · Jordan Valley Dermatology, South Jordan
Registry updated 2026-10-20
NCT07765888
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
Trial Treatment · Phase 3 · Pfizer
Kern Research, Inc, Bakersfield · Cahaba Dermatology Skin Health Center, Birmingham · Derm Texas, Dallas · Red River Research Partners, LLC, Fargo · Marietta Dermatology Clinical Research, Inc., Marietta · Pediatric Skin Research, Miami · Northridge Clinical Trials, Northridge · AllerVie Clinical Research, Panama City · University Clinical Trials, Inc, San Diego · Aeroallergy Research Laboratories of Savannah, Inc., Savannah · Orso Health, Scottsdale · Stryde Research-Epiphany Dermatology, Southlake · GCP Research, Global Clinical professionals, St. Petersburg · Focus Clinical Research, West Hills
Registry updated 2026-10-15
NCT07527923
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Trial Treatment · Phase 1 · Regeneron Pharmaceuticals
Cahaba Dermatology & Skin Health Center, LLC, Birmingham · Florida International Research Center, Miami · National Allergy and Asthma Research, LLC, North Charleston · Arkansas Research Trials, North Little Rock · Texas Dermatology and Laser Specialists, San Antonio · Alliance Clinical West Hills (Focus Clinical Research), West Hills
Registry updated 2026-10-07
NCT06947993
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Trial Treatment · Phase 2 · Novartis Pharmaceuticals
Arlington · Atlanta · Birmingham · Brighton · Brooklyn · Cypress · Dallas · Fort Smith · Fountain Valley · Houston · Los Angeles · Louisville · Macon · Miami · Portsmouth · Sacramento · Saint Joseph · San Antonio · Santa Ana · Santa Monica · St. Petersburg · Troy · Washington D.C.
Registry updated 2026-09-28
NCT06807268
A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
Trial Treatment · Phase 3 · Pfizer
Cahaba Dermatology & Skin Health Center, LLC, Birmingham · Medical University of South Carolina - Walton Research Building, Charleston · Medical University of South Carolina - Department of Dermatology, Charleston · Medical University of South Carolina - South Carolina Translational Research Nexus Clinic, Charleston · Tribe Clinical Research LLC, Greenville · Dawes Fretzin Clinical Research Group, LLC, Indianapolis · Solutions Through Advanced Research, Jacksonville · Ada West Research, Meridian · Arkansas Research Trials, North Little Rock · Texas Dermatology and Laser Specialists, San Antonio · Investigational Drug Service - Rady Childrens Hospital-San Diego, San Diego · University of California, San Diego/Rady Children's Hospital-San Diego; Pediatric & Adolescent Derm, San Diego · Saint Louis University - Department of Dermatology, St Louis
Registry updated 2026-09-25
NCT07447063
The Impact of Dietary Salt on the Severity of Eczema
Trial Treatment · Phase 4 · University of California, San Francisco
UCSF Mt Zion Campus, San Francisco · San Francisco VA Medical Center, San Francisco
Registry updated 2026-09-10
NCT07487831
The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease
Trial Treatment · Phase 4 · University of California, San Francisco
UCSF Mt Zion Campus, San Francisco · San Francisco VA Medical Center, San Francisco
Registry updated 2026-09-09
NCT07355075
A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)
Trial Treatment · Phase 2/3 · Turn Therapeutics
ALS Global, Irving
Registry updated 2026-09-04
NCT07599813
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Trial Treatment · Phase 2 · Apollo Therapeutics Ltd
AllerVie Clinical Research, Birmingham · Cahaba Dermatology and Skin Health Center, Birmingham · Dermatology Trial Associates, Inc., Bryant · Best Skin Research, LLC, Camp Hill · ABMED Clinical Research Corp., Cape Coral · DS Research of Southern Indiana,LLC, Clarksville · Trail Horizon, Clifton · ClinOhio Research Services, Columbus · Red River Research Partners, LLC, Fargo · Skin Care Research, Hollywood · Marvel Research, LLC, Huntington Beach · Dawes Fretzin Clinical Research Group, LLC, Indianapolis · University of California, Los Angeles, Los Angeles · Metropolis Dermatology, Los Angeles · Dermatology Research Associates, Los Angeles · Ada West Research, LLC, Meridian · Quality Care Clinical Research, Miami · FXM Clinical Research Miami LLC, Miami · Sadick Research Group, LLC, New York · Eminent Clinical Research and Associates, North Lauderdale · Ziaderm Research LLC, North Miami Beach · Northridge Clinical Trials, Northridge · Chesapeake Clinical Research, Inc, Pasadena · Saguaro Dermatology Associates, Phoenix · UPMC Department of Dermatology, Pittsburgh · Skin Cancer and Dermatology Institute, Reno · Integrative Skin Science and Research, Sacramento · Progressive Clinical Research, PA, San Antonio · Georgia Skin & Cancer Center, Savannah · Endeavor Health, Skokie · NMC Research LLC, Tampa · Valiance Clinical Research - Tarzana, Tarzana · Paradigm Clinical Research Centers, LLC: Wheat Ridge, Wheat Ridge
Registry updated 2026-08-28
NCT07598058
PPDTM CorEvitasTM Chronic Hand Eczema (CHE) Drug Safety and Effectiveness Registry
Research · CorEvitas
CorEvitas, LLC, Waltham
Registry updated 2026-08-26
NCT07560618
Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream.
Trial Treatment · Phase 4 · Integrative Skin Science and Research
Integrative Skin Science and Research, Sacramento
Registry updated 2026-08-13
NCT07037901
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Trial Treatment · Phase 2 · Inmagene LLC
Anderson · Burien · Charlotte · Columbus · Fargo · Kew Gardens · Lancaster · Los Angeles · Mayfield Heights · New York · Ocala · Portland · Rolling Meadows · Southlake · Tampa · Woodbury
Registry updated 2026-08-12
NCT07734415
Long-term Safety and Efficacy Evaluation of IMG-007 in Participants With Moderate-to-Severe Atopic Dermatitis
Trial Treatment · Phase 2 · Inmagene LLC
Anderson · Burien · Charlotte · Columbus · Fargo · Kew Gardens · Lancaster · Los Angeles · Mayfield Heights · New York · Ocala · Portland · Rolling Meadows · Southlake · Tampa · Woodbury
Registry updated 2026-07-29
NCT06998446
Sodium in the Skin and Atopic Dermatitis
Research · University of California, San Francisco
San Francisco VA Medical Center, San Francisco · UCSF Mt Zion Campus, San Francisco
Registry updated 2026-07-14
NCT06504160
Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
Trial Treatment · Phase 1 · National Institute of Allergy and Infectious Diseases (NIAID)
Northwestern University Feinberg School of Medicine, Department of Dermatology, Chicago · Cincinnati Children's Hospital Medical Center: Asthma Center, Cincinnati · National Jewish Health: Division of Pediatric Allergy and Clinical Immunology, Denver · University of Wisconsin School of Medicine and Public Health: Division of Pediatric Allergy, Immunology and Rheumatology, Madison · New York University Langone Health: Department of Pediatric Allergy and Immunology, New York · Icahn School of Medicine at Mount Sinai: Department of Pediatrics Allergy & Immunology, New York · University of Rochester Medical Center: Department of Dermatology, Rochester · University of California, San Diego: Dermatology Clinical Trials Unit, San Diego
Registry updated 2026-07-02

All Atopic dermatitis (eczema) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error